↓ Skip to main content

Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes

Overview of attention for article published in Drug Design, Development and Therapy, October 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent
5 patents
wikipedia
1 Wikipedia page

Readers on

mendeley
93 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes
Published in
Drug Design, Development and Therapy, October 2008
DOI 10.2147/dddt.s3225
Pubmed ID
Authors

Gina Ryan, Tim A Briscoe, Lynette Jobe

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
Unknown 92 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 17%
Student > Bachelor 10 11%
Researcher 8 9%
Student > Ph. D. Student 7 8%
Other 6 6%
Other 19 20%
Unknown 27 29%
Readers by discipline Count As %
Medicine and Dentistry 21 23%
Agricultural and Biological Sciences 14 15%
Pharmacology, Toxicology and Pharmaceutical Science 10 11%
Biochemistry, Genetics and Molecular Biology 6 6%
Nursing and Health Professions 3 3%
Other 8 9%
Unknown 31 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 July 2024.
All research outputs
#3,004,765
of 26,291,905 outputs
Outputs from Drug Design, Development and Therapy
#162
of 2,288 outputs
Outputs of similar age
#8,857
of 103,413 outputs
Outputs of similar age from Drug Design, Development and Therapy
#2
of 6 outputs
Altmetric has tracked 26,291,905 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,288 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 103,413 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.